Stanley Crooke
Founder and CEO of n-Lorem (Enlorem) and the scientist behind antisense oligonucleotide (ASO) technology, describing the foundation's work providing ASO treatments for nano-rare genetic diseases.
Best podcasts with Stanley Crooke
Ranked by the Snipd community
Jan 30, 2026 • 43min
The Path with Becky Quick: Finding Hope 1/30/26
Dr. Stanley Crooke, founder of n-Lorem and pioneer of antisense oligonucleotide therapy, and Luke Rosen, parent-advocate who founded KIF1A.org after his daughter’s diagnosis. They discuss ultra-rare KIF1A disease, how personalized ASO treatments are developed and delivered, the emotional and logistical journey of seeking care, and barriers families face accessing research and therapies.
